Clinical, anamnestic, molecular and genetic criteria for Lynch syndrome

Lynch syndrome is the most common cancer-prone syndrome associated with a high risk of colorectal cancer (CRC), neoplasms of the upper gastrointestinal system, the urinary tract, the female reproductive system, brain tumours and others. The only known form of hereditary endometrial cancer is also di...

Full description

Saved in:
Bibliographic Details
Main Authors: A. V. Semyanikhina, N. I. Pospekhova, M. G. Filippova, D. A. Golovina, A. O. Rasulov, L. N. Lyubchenko
Format: Article
Language:Russian
Published: ABV-press 2019-12-01
Series:Успехи молекулярной онкологии
Subjects:
Online Access:https://umo.abvpress.ru/jour/article/view/240
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850025122321137664
author A. V. Semyanikhina
N. I. Pospekhova
M. G. Filippova
D. A. Golovina
A. O. Rasulov
L. N. Lyubchenko
author_facet A. V. Semyanikhina
N. I. Pospekhova
M. G. Filippova
D. A. Golovina
A. O. Rasulov
L. N. Lyubchenko
author_sort A. V. Semyanikhina
collection DOAJ
description Lynch syndrome is the most common cancer-prone syndrome associated with a high risk of colorectal cancer (CRC), neoplasms of the upper gastrointestinal system, the urinary tract, the female reproductive system, brain tumours and others. The only known form of hereditary endometrial cancer is also diagnosed as part of Lynch syndrome. One or more pathogenic germline mutations in one of the mismatch repair (MMR) genes are the cause of Lynch syndrome. Mapping of MMR genes and the discovery of microsatellite instability (MSI) have given rise to the possibility of using these clue characteristics of the pathogenic process for the elaboration of a screening test for Lynch syndrome. Being highly accurate and superior to all previously developed clinical criteria and guidelines, MSI-testing along with the assessment of the expression patterns of MMR proteins by immunohistochemistry has taken the leading role in the early diagnosis of Lynch syndrome. This article focuses on a brief review about the main evolutionary stages of clinical, anamnestic, molecular and genetic criteria for Lynch syndrome together with the results of our own research on the accuracy of the Amsterdam criteria, the Bethesda guidelines and MSI-diagnostics in the determination of the indications for MMR-genotyping in colorectal cancer patients suspected for Lynch syndrome.
format Article
id doaj-art-8017a5f744ae4a088ece4fdc09f16f17
institution DOAJ
issn 2313-805X
2413-3787
language Russian
publishDate 2019-12-01
publisher ABV-press
record_format Article
series Успехи молекулярной онкологии
spelling doaj-art-8017a5f744ae4a088ece4fdc09f16f172025-08-20T03:00:55ZrusABV-pressУспехи молекулярной онкологии2313-805X2413-37872019-12-0164384610.17650/2313-805X-2019-6-4-38-46172Clinical, anamnestic, molecular and genetic criteria for Lynch syndromeA. V. Semyanikhina0N. I. Pospekhova1M. G. Filippova2D. A. Golovina3A. O. Rasulov4L. N. Lyubchenko5N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of RussiaN.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of RussiaN.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of RussiaN.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of RussiaN.A. Lopatkin Research Institute of Urology and Interventional Radiology – branch of National Medical Research Radiological Center, Ministry of Health of the RussiaN.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia; I.M. Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of RussiaLynch syndrome is the most common cancer-prone syndrome associated with a high risk of colorectal cancer (CRC), neoplasms of the upper gastrointestinal system, the urinary tract, the female reproductive system, brain tumours and others. The only known form of hereditary endometrial cancer is also diagnosed as part of Lynch syndrome. One or more pathogenic germline mutations in one of the mismatch repair (MMR) genes are the cause of Lynch syndrome. Mapping of MMR genes and the discovery of microsatellite instability (MSI) have given rise to the possibility of using these clue characteristics of the pathogenic process for the elaboration of a screening test for Lynch syndrome. Being highly accurate and superior to all previously developed clinical criteria and guidelines, MSI-testing along with the assessment of the expression patterns of MMR proteins by immunohistochemistry has taken the leading role in the early diagnosis of Lynch syndrome. This article focuses on a brief review about the main evolutionary stages of clinical, anamnestic, molecular and genetic criteria for Lynch syndrome together with the results of our own research on the accuracy of the Amsterdam criteria, the Bethesda guidelines and MSI-diagnostics in the determination of the indications for MMR-genotyping in colorectal cancer patients suspected for Lynch syndrome.https://umo.abvpress.ru/jour/article/view/240colorectal cancerlynch syndromethe amsterdam criteriathe bethesda guidelinesmicrosatellite instability
spellingShingle A. V. Semyanikhina
N. I. Pospekhova
M. G. Filippova
D. A. Golovina
A. O. Rasulov
L. N. Lyubchenko
Clinical, anamnestic, molecular and genetic criteria for Lynch syndrome
Успехи молекулярной онкологии
colorectal cancer
lynch syndrome
the amsterdam criteria
the bethesda guidelines
microsatellite instability
title Clinical, anamnestic, molecular and genetic criteria for Lynch syndrome
title_full Clinical, anamnestic, molecular and genetic criteria for Lynch syndrome
title_fullStr Clinical, anamnestic, molecular and genetic criteria for Lynch syndrome
title_full_unstemmed Clinical, anamnestic, molecular and genetic criteria for Lynch syndrome
title_short Clinical, anamnestic, molecular and genetic criteria for Lynch syndrome
title_sort clinical anamnestic molecular and genetic criteria for lynch syndrome
topic colorectal cancer
lynch syndrome
the amsterdam criteria
the bethesda guidelines
microsatellite instability
url https://umo.abvpress.ru/jour/article/view/240
work_keys_str_mv AT avsemyanikhina clinicalanamnesticmolecularandgeneticcriteriaforlynchsyndrome
AT nipospekhova clinicalanamnesticmolecularandgeneticcriteriaforlynchsyndrome
AT mgfilippova clinicalanamnesticmolecularandgeneticcriteriaforlynchsyndrome
AT dagolovina clinicalanamnesticmolecularandgeneticcriteriaforlynchsyndrome
AT aorasulov clinicalanamnesticmolecularandgeneticcriteriaforlynchsyndrome
AT lnlyubchenko clinicalanamnesticmolecularandgeneticcriteriaforlynchsyndrome